The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
MIRATI THERAPEUTICS INC | COMMON | 60468T105 | 10,877 | 1,992,085 | SH | DFND | 1 | 0 | 0 | 1,992,085 | |
NORTEL INVERSORA S A | SPON ADR PFD B | 656567401 | 15,404 | 543,926 | SH | DFND | 1 | 0 | 0 | 543,926 | |
NORTEL INVERSORA S A | SPON ADR PFD B | 656567401 | 100,922 | 3,563,640 | SH | DFND | 2 | 0 | 0 | 3,563,640 |